Tweet
Seems that turf wars have suppressed a treatment that could have save lives.
Wonder drug that works? Monoclonal antibodies ‘cured’ my grandparents from COVID
US government health bodies warn there’s not nearly enough data to prove efficacy, but doctors report no deaths among thousands of high-risk patients prescribed the new treatment
By Julie Masis 28 January 2021, 5:52 pm
...
Now that doctors have been treating patients with monoclonal antibody infusions for about two months, some have stronger evidence that these medications not only prevent deaths but decrease hospitalization rates.
Among Razonable’s 2,000 patients at the Mayo Clinic, only 3% of infusion recipients had to be hospitalized, which is nearly five times lower than the Centers for Disease Control’s estimated 13.8% hospitalization rate for elderly COVID patients.
“It does work as long as it’s given early,” says Razonable.
The hospitalization rate among Huang’s elderly patients in Texas is about 4% — again, significantly lower than average for elderly people with COVID.
Dr. Howard Huang. (Courtesy)
Patients who did need to be hospitalized spent only four days in the hospital on average — “relatively short compared to a lot of COVID cases,” says Huang.
“When you see that the hospitalization rate [in the field] looks similar to the clinical trial, it seems that there is something to what the clinical trial found,” he said.
Still, many hospitals and doctors continue to be reluctant to offer the new treatment....
See also:
Only about a quarter of the doses of monoclonal antibodies that were shipped to hospitals across the country has been used - doctors unaware of this COVID-19 treatment
Wonder drug that works? Monoclonal antibodies ‘cured’ my grandparents from COVID
US government health bodies warn there’s not nearly enough data to prove efficacy, but doctors report no deaths among thousands of high-risk patients prescribed the new treatment
By Julie Masis 28 January 2021, 5:52 pm
...
Now that doctors have been treating patients with monoclonal antibody infusions for about two months, some have stronger evidence that these medications not only prevent deaths but decrease hospitalization rates.
Among Razonable’s 2,000 patients at the Mayo Clinic, only 3% of infusion recipients had to be hospitalized, which is nearly five times lower than the Centers for Disease Control’s estimated 13.8% hospitalization rate for elderly COVID patients.
“It does work as long as it’s given early,” says Razonable.
The hospitalization rate among Huang’s elderly patients in Texas is about 4% — again, significantly lower than average for elderly people with COVID.
Dr. Howard Huang. (Courtesy)
Patients who did need to be hospitalized spent only four days in the hospital on average — “relatively short compared to a lot of COVID cases,” says Huang.
“When you see that the hospitalization rate [in the field] looks similar to the clinical trial, it seems that there is something to what the clinical trial found,” he said.
Still, many hospitals and doctors continue to be reluctant to offer the new treatment....
See also:
Only about a quarter of the doses of monoclonal antibodies that were shipped to hospitals across the country has been used - doctors unaware of this COVID-19 treatment
Comment